Table 1.

Number of cases and health care expenditures avoided associated with non-pharmaceutical interventions

Diseases	Total	Male	Female	0‒4 years	5‒19 years	≥ 20 years
Number of cases avoided‒thousand (95% CI)
Seasonal influenza	1807 (1185‒2705)	951 (626‒1419)	856 (558‒1289)	802 (521‒1214)	738 (467‒1153)	327 (215‒480)
Tuberculosis	93 (64‒124)	70 (50‒91)	25 (15‒35)	0 (-0‒0)	6 (4‒9)	87 (59‒117)
Measles	5 (3‒10)	3 (2‒6)	2 (1‒4)	2 (1‒4)	1 (0‒1)	2 (1‒4)
Scarlet fever	66 (51‒85)	40 (31‒51)	27 (20‒35)	20 (16‒26)	46 (35‒60)	0 (0‒1)
Mumps	65 (43‒91)	39 (26‒54)	26 (17‒37)	2 (-1‒5)	54 (35‒77)	7 (5‒9)
Rubella	3 (1‒8)	2 (1‒6)	1 (0‒3)	0 (0‒0)	2 (0‒7)	1 (1‒2)
Varicella	399 (330‒475)	211 (174‒250)	190 (156‒226)	65 (49‒83)	266 (217‒318)	83 (71‒96)
Bacillary Dysentery	16 (11‒21)	8 (5‒11)	8 (5‒11)	6 (4‒8)	1 (0‒2)	8 (5‒11)
Infectious diarrhea	441 (316‒578)	246 (179‒319)	197 (138‒262)	293 (217‒378)	9 (-2‒22)	128 (72‒190)
HFMD	2235 (1441‒3320)	1309 (850‒1935)	923 (590‒1377)	1978 (1285‒2917)	232 (151‒343)	14 (8‒22)
Health care expenditures avoided‒million USD (95% CI)
Seasonal influenza	826 (542‒1237)	435 (286‒649)	391 (255‒589)	367 (238‒555)	337 (214‒527)	149 (98‒219)
Tuberculosis	138 (94‒183)	103 (73‒134)	36 (22‒52)	0 (− 0‒0)	10 (6‒13)	129 (87‒172)
Measles	2 (1‒4)	1 (1‒3)	1 (1‒2)	1 (1‒2)	0 (0‒1)	1 (0‒2)
Scarlet fever	24 (18‒31)	14 (11‒18)	10 (7‒12)	7 (6‒9)	17 (13‒22)	0 (0‒0)
Mumps	21 (14‒30)	13 (8‒18)	9 (6‒12)	1 (-0‒2)	18 (11‒25)	2 (2‒3)
Rubella	0 (0‒1)	0 (0‒0)	0 (0‒0)	-0 (-0‒0)	0 (0‒0)	0 (0‒0)
Varicella	68 (56‒80)	36 (29‒42)	32 (26‒38)	11 (8‒14)	45 (37‒54)	14 (12‒16)
Bacillary Dysentery	8 (6‒11)	4 (3‒6)	4 (3‒6)	3 (2‒4)	1 (0‒1)	4 (3‒6)
Infectious diarrhea	103 (74‒135)	58 (42‒75)	46 (32‒61)	69 (51‒89)	2 (-1‒5)	30 (17‒44)
HFMD	580 (374‒861)	340 (220‒502)	239 (153‒357)	513 (333‒757)	60 (39‒89)	4 (2‒6)

HFMD: Hand, foot, and mouth disease; CI: Confidential interval; USD: United States Dollars